Embleema (RWE) - ICO Details
Embleema ICO Summary
Embleema is bringing blockchain solution in the Drugs & Healthcare industry.
Their initial coin offering will be held from October 10, 2019 and investors will be able to buy it until January 1, 2020.
A total of 500,000,000 RWE will be created and 150,000,000 will be available during the coin offering.
RWE sale will be considered successful if their softcap of 2,000,000(USD) is reached. Please keep in mind that the sale could end before January 1, 2020 if the hardcap of 30,000,000(USD) is reached.
During Embleema ICO, investors will be able to buy RWE at 0.2 USD per Coin/Token.
Get all the details about Embleema below and on Embleema Official ICO website
Embleema Project Info
Embleema’s blockchain network offers a novel way to put patients at the center of clinical research by letting them own their health data, disrupting the slow, costly, manual and opaque process by which low quality health data is currently collected by pharmaceutical companies through Contrat Research Organisation, to monitor the efficacy of new investigational drugs.
Connecting patients directly to medical research and incentivizing them to share their data with tokens, blockchain is the decentralized technology everyone was waiting for to move away from the current linear process of drug approvals, to a new iterative model where trustworthy digital health data is shared in real time between patients, life sciences and regulators.
The 21st Century Cures Act (2016) gave the FDA a mandate to accelerate approvals if more patient real world data was shared proactively by pharma. Embleema’s blockchain speeds up this process with patient buy-in, accelerating time to market new drugs.
Embleema ICO Details
Embleema Stage Details
|Token for sale||150,000,000|
|Token Price||0.2 USD|